MDSCs can also regulate VEGF bioavailability through inducing high levels of matrix metalloprotease 9 (MMP9) and pro-MMP9 to stimulate tumor growth and metastases in CRC (136, 137). The gene discussed is VEGFA; the disease is neoplasm.